Lamotrigine in the treatment of bipolar disorder

Expert Opinion on Pharmacotherapy

Volumn 3, Issue 10, 2002, Pages 1513-1519

  Bowden, Charles L ^a   Karren, Nancy U ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Bipolar; Depression; Lamotrigine; Manic depressive; Treatment

Indexed keywords

ANTIDEPRESSANT AGENT; CALCIUM ION; CARBAMAZEPINE; LAMOTRIGINE; LITHIUM; NEUROLEPTIC AGENT; PLACEBO; SODIUM ION; VALPROIC ACID;

ARTICLE; CALCIUM CURRENT; CLINICAL FEATURE; CLINICAL STUDY; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; HYPOMANIA; INHIBITION KINETICS; LONG TERM CARE; MANIA; MANIC DEPRESSIVE PSYCHOSIS; MEDICAL DECISION MAKING; MONOTHERAPY; POSTTRAUMATIC STRESS DISORDER; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RASH; RECURRENT DISEASE; SODIUM CURRENT; STEVENS JOHNSON SYNDROME; SYMPTOMATOLOGY;

ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; HUMANS; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; TRIAZINES;

EID: 0036796487     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.3.10.1513     Document Type: Article

References (37)

1. NEMEROFF CB: An ever-increasing pharmacopeia for the management of patients with bipolar disorder. J. Clin. Psychiatr. (2002) 61(Suppl. 13):19-25.
2. COHN JB, COLLINS G, ASHBROOK E, WERNICKE JF: A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder. Int. Clin. Psychopharmacol. (1989) 4:313-322.
3. SACHS GS, PRINTZ DJ, KAHN DA, CARPENTER D, DOCHERTY JP: The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder. McGraw-Hill Companies(2000):1-108.
4. HIMMELHOCH JM, FUCHS CZ, SYMONS BJ: A double-blind study of tranylcypomine treatment of major anergic depression. J. Nerv. Ment. Dis. (1982) 170:628-634.
5. PRIEN RF, KLETT CJ, CAFFEY EM: Lithium carbonate and imipramine in prevention of affective episodes. Arch. Gen. Pychiatr. (1973) 29:420-425.
6. QUITKIN FM, KANE J, RIFKIN A, RAMOS-LORENZI JR, NAYAK DV: Prophylactic lithium carbonate with and without imipramine for bipolar I patients: A double-blind study. Arch. Gen. Pychiatr. (1981) 38:902-907.
7. SMITH D, BAKER G, DAVIES G, DEWEY M, CHADWICK DW: Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia (1993) 34:312-322.
8. MESSENHEIMER J, MULLENS EL, GIORGI L, YOUNG F: Safety of adult clinical trial experience with lamotrigine. Drug Safety (1998) 18:281-296.
9. LEES G, LEACH MJ: Studies on the mechanism of action of the novel anticonvulsant lamotrigine (lamictal) using primary neuroglial cultures from rat cortex. Brain Res. (1993)612:190-199.
10. MCGEER EG, ZHU SG: Lamotrigine protects against kainate but not ibotenate lesions in rat striatum. Neurosci. Lett. (1990) 112:348-351.
11. LEACH MJ, MARDEN CM, MILLER AA: Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action. Epilepsia (1986) 27:490-497.
12. BAUKROWITZ T, YELLEN G: Use dependent blockers and exit rate of the last ion from the multi-ion pore of a K+ channel. Science (1996) 271:653-656.
13. CALABRESE JR, BOWDEN CL, MCELROY SL et al.: Spectrum of activity of lamot ri gine in treatment-refractory bipolar disorder. Am. J. Psychiatr.(1999) 156:1019-1023.
14. BOWDEN CL, CALABRESE JR, MCELROY SL et al.: The efficacy of lamotrigine in rapid cycling and non-rapid cycling patients with bipolar disorder. Biol Psychiatr (1999) 45:953-958.
15. CALABRESE JR, FATEMI SH, WOYSHVILLE MJ: Antidepressant effects of lamotrigine in bipolar rapid cycling. Am. J. Psychiatr. (1996) 153:1236.
16. CALABRESE JR, BOWDEN CL, SACHS GS, ASCHER JA, MONAGHAN E, RUDD DG: A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. J. Clin. Psychiatr. (1999) 60:79-88.
17. BOWDEN CL, MITCHELL P, SUPPES T: Lamotrigine in the treatment of biopolar depression. Eur. Neuropsychopharmacol. (1999) 9(Suppl. 4):S113-S-117.
18. MONTGOMERY SA, ASBERG M: A new depression scale designed to be sensitive to change. Br J. Psychiatr. (1979) 134:382-389.
19. FRYE MA, KETTER TA, KIMBRELL TA et al.: A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J. Clin. Psychopharmacol. (2000) 20:607-614.
20. ASCHER J, BARNETT S, BATEY S: Safety and tolerability of lamotrigine in controlled mood disorder trials. 2001 Annual Meeting of the American Psychiatric Association New Orleans, LA, USA (5-10 May 2001).
21. BOWDEN CL, CALABRESE JR, SACHS G et al.: A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch. Gen. Pychiatr. (2002) In press.
22. BOWDEN CL, GHAEMI N, GYULAI L et al.: Lamotrigine delays mood episodes in recently depressed bipolar I patients. New research. 155th American Psychiatric Association Annual Meeting. Philadelphia, PA, USA (18-23 May 2002).
23. PRIEN RF, CAFFEY EM, KLETT CJ. Prophylactic efficacy of lithium carbonate in manic-depressive illness. Arch. Gen. Psychiatr. (1973) 28:337-341.
24. PRIEN RF, KLETT CJ, CAFFEY EM JR: Lithium prophylaxis in recurrent affective illness. Am. J. Psychiatr. (1974) 131:198-202.
25. CALABRESE JR, SUPPES T, BOWDEN CL et al.: A double-blind placebo-controlled prophylaxis study of lamotrigine in rapid cycling bipolar disorder. J. Clin. Psychiatr. (2000) 61:841-850.
26. KUSUMAKAR V, YATHAM L: Lamotrigine treatment of rapid cycling bipolar disorder. Am. J. Psychiatr. (1997) 154:1171-1172.
27. ANGST J: The emerging epidemiology of hypomania and bipolar II disorder. J. Affect. Disord. (1998) 50:143-151.
28. BENAZZI F: Prevalence of bipolar II disorder in outpatient depression: A 203-case study in private practice. J. Affect. Disord. (2002) 43:163-166.
29. AKISKAL HS, MASER JD, ZELLER PJ, ENDICOTT J, CORYELL W, KELLER M: Switching from 'unipolar' to bipolar II. An 11-year prospective study of clinical and temperamental predictors in 559 patients. Arch. Gen. Psychiatr. (1995) 52:114-123.
30. SUPPES T, BROWN ES, MCELROY SL et al.: Lamotrigine for the treatment of bipolar disorder: a clincial case series. J. Affect. Disord. (1999) 53:95-98.
31. HERTZBERG MA, BUTTERFIELD MI, FELDMAN ME et al.: A preliminary study of lamotrigine or the treatment of posttraumatic stress disorder. Biol. Psychiatr. (1999) 45:1226-1229.
32. FOGELSON DL, STERNBACH H: Lamotrigine treatment of refractory bipolar disorder. J. Clin. Psychiatr. (1997) 58:271-273.
33. WALDEN J, HESSLINGER B, VAN CALKER D, BERGER M: Addition of lamotrigine to valproate may enhance efficacy in the treatment of bipolar affective disorder. Pharmacopsychiatry (1996) 29:193-195.
34. TENNIS P: Nine-year interim results of the lamotrigine pregnancy registry. New research presentation. 155th American Psychiatic Association Annual Meeting. Philadelphia, PA, USA (18-23 May 2002).
35. FATEMI SH, RAPPORT DJ, CALABRESE JR, THURAS P: Lamotrigine in rapid-cycling bipolar disorder. J. Clin. Psychiatr. (2002) 58:522-527.
36. GLUE PW, NUTT DJ, COWEN PJ, BROADBENT D: Selective effect of lithium on cognitive performance in man. Psychopharmacologia (1987) 91:109-111.
37. HIRSCHFELD RMA, BOWDEN CL, GITLIN MJ, KECK PE, SUPPES T, THASE ME: Practice guideline for the treatment of patients with bipolar disorder (revision). Am. J Psychiatr. (2002) 159:1-50.